Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

InspireMD (NSPR) EBIT Margin (2016 - 2025)

InspireMD filings provide 16 years of EBIT Margin readings, the most recent being 866.88% for Q4 2025.

  • On a quarterly basis, EBIT Margin fell 2727.0% to 866.88% in Q4 2025 year-over-year; TTM through Dec 2025 was 113.95%, a 1823.0% decrease, with the full-year FY2025 number at 113.95%, down 1823.0% from a year prior.
  • EBIT Margin hit 866.88% in Q4 2025 for InspireMD, up from 517.28% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 894.15% in Q4 2024 to a low of 749.51% in Q1 2025.
  • Median EBIT Margin over the past 5 years was 358.0% (2023), compared with a mean of 292.48%.
  • Biggest five-year swings in EBIT Margin: surged 206831bps in 2021 and later crashed -25884bps in 2025.
  • InspireMD's EBIT Margin stood at 284.86% in 2021, then tumbled by -69bps to 481.09% in 2022, then skyrocketed by 31bps to 329.81% in 2023, then skyrocketed by 371bps to 894.15% in 2024, then fell by -3bps to 866.88% in 2025.
  • The last three reported values for EBIT Margin were 866.88% (Q4 2025), 517.28% (Q3 2025), and 732.23% (Q2 2025) per Business Quant data.